MDS Virtual Congress 2020 Archives - Page 43 of 149

Development and validation of a proﬁle of peripheral immune biomarkers for Parkinson’s disease: A multicenter, retrospective study

Y. Li, J. Liu (Shanghai, China)
Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10)

J. Vizcarra, A. Merola, D. Torres-Russotto, G. Stebbins, A. Wagle Shukla, A. Hassan, L. Marsili, J. Krauss, R. Elble, G. Deuschl, A. Espay (Atlanta, GA, USA)
Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials

S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)
Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage

K. Bird, M.H Saint-Hilaire, G. Curiale, S. O'Shea (Boston, MA, USA)
Development of novel treatment strategies for SGCE dystonia using patient-derived induced pluripotent stem cells (iPSCs)

S. Staege, A. Kutschenko, P. Seibler, K. Grütz, A. Hermann, F. Wegner (Hannover, Germany)
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism

B. Heim, S. Mangesius, F. Krismer, A. Hussl, G.K Wenning, E.R Gizewski, M. Schocke, W. Poewe, K. Seppi (Innsbruck, Austria)
Diagnostic Demography of the Ataxia Unit at UNIFESP: 12 years experience

B. Massuyama, M. Gama, F. Abrantes, F. Filho, F. Maggi, R. Salomao, J. Freitas, S. Costa, I. Raslan, G. Diaferia, P. Matos, V. Ciarlariello, C. Jaques, M. Moraes, J. Pedroso, O. Barsottini (Sao Paulo, Brazil)
Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)
Diagnostic value of olfactory dysfunction in Parkinson’s disease

K. Stepanchenko, V. Marchenko, A. Zhidkova (Kharkiv, Ukraine)
Diagnostic value of vagus nerve ultrasound in Parkinson’s disease

M. Abo Srea, N.A Kishk, R. Soliman, A. Alsayyad, M. Oraby (Beni-Suef, Egypt)